Inflammation and nutrition in renal insufficiency.

作者: Kamyar Kalantar-Zadeh , Peter Stenvinkel , Luana Pillon , Joel D Kopple

DOI: 10.1053/J.ARRT.2003.08.008

关键词:

摘要: Protein-energy malnutrition (PEM) and inflammation are common in patients with chronic kidney disease (CKD) worsen as the CKD progresses toward end-stage renal (ESRD). These conditions major predictors of poor clinical outcome failure, reflected by a strong association between hypoalbuminemia cardiovascular (CVD). It has been suggested that is cause both PEM CVD and, hence, main link among these conditions, but hypotheses not well established. Increased release or activation inflammatory cytokines, such interleukin-6 tumor necrosis factor alpha, may suppress appetite, muscle proteolysis hypoalbuminemia, be involved atherogenesis. Increasing serum levels proinflammatory cytokines caused reduced function, volume overload, oxidative carbonyl stress, decreased antioxidants, increased susceptibility to infection uremia, presence comorbid lead patients. In hemodialysis patients, exposure dialysis tubing membranes, quality water, back-filtration back-diffusion contaminants, foreign bodies access maybe additional causes inflammation. Similarly, episodes overt latent peritonitis, peritoneal (PD) catheter its related infections, constant PD solution contribute The degree which clear. Because strongly associated each other can change many nutritional measures concurrently same direction, terms malnutrition-inflammation complex syndrome (MICS) and/or malnutrition-inflammation-atherosclerosis (MIA) have denote important contribution outcome. Maintenance who underweight low cholesterol, creatinine, homocysteine suffering from MICS/MIA subsequent Consequently, obesity hypercholesterolemia appear protective, known reverse epidemiology. Although significant reversing traditional risk factors it clear whether their complications effectively managed ESRD management improves

参考文章(108)
W M O'Fallon, S E Gabriel, C S Crowson, Mortality in rheumatoid arthritis: Have we made an impact in 4 decades? The Journal of Rheumatology. ,vol. 26, pp. 2529- 2533 ,(1999)
Anthony F. Suffredini, Giamila Fantuzzi, Raffaele Badolato, Joost J. Oppenheim, Naomi P. O'Grady, New insights into the biology of the acute phase response. Journal of Clinical Immunology. ,vol. 19, pp. 203- 214 ,(1999) , 10.1023/A:1020563913045
Vera Vlacich, Kathy Reydel, Georgina Delosreyes, Imran Rajwani, Jaime Uribarri, Eli A. Friedman, Onyekachi Ifudu, Low hematocrit may connote a malnutrition/inflammation syndrome in hemodialysis patients Dialysis & Transplantation. ,vol. 31, pp. 845- 847 ,(2002)
O Boenisch, R Schindler, U Frei, C Fischer, Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clinical Nephrology. ,vol. 53, pp. 452- 459 ,(2000)
Kamyar Kalantar-Zadeh, Shaul G. Massry, Joel D. Kopple, Nutritional management of renal disease Elsevier/Academic. ,(1997)
K L Streetz, C Trautwein, M P Manns, T Wüstefeld, C Klein, Mediators of inflammation and acute phase response in the liver. Cellular and Molecular Biology. ,vol. 47, pp. 661- 673 ,(2001)
M. H. A. Bemelmans, D. J. Gouma, W. A. Buurman, Influence of nephrectomy on tumor necrosis factor clearance in a murine model. Journal of Immunology. ,vol. 150, pp. 2007- 2017 ,(1993)
A Herbelin, P Roux-Lombard, A Moynot, C Verger, P Jungers, A T Nguyen, D Dahmane, J Zingraff, D de Groote, B Descamps-Latscha, Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. Journal of Immunology. ,vol. 154, pp. 882- 892 ,(1995)
Alberto Zanchetti, Kenneth Jamerson, Hans Wedel, Luis M. Ruilope, Antonio Salvetti, Lennart Hansson, Ingrid Warnold, Renal Function and Intensive Lowering of Blood Pressure in Hypertensive Participants of the Hypertension Optimal Treatment (HOT) Study Journal of The American Society of Nephrology. ,vol. 12, pp. 218- 225 ,(2001) , 10.1681/ASN.V122218
J Carlos Ayus, D Sheikh-Hamad, None, Silent infection in clotted hemodialysis access grafts. Journal of The American Society of Nephrology. ,vol. 9, pp. 1314- 1317 ,(1998) , 10.1681/ASN.V971314